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Abstract Tight junctions create a paracellular barrier in
epithelial and endothelial cells protecting them from the
external environment. Two diVerent classes of integral
membrane proteins constitute the tight junction strands in
epithelial cells and endothelial cells, occludin and members
of the claudin protein family. In addition, cytoplasmic
scaVolding molecules associated with these junctions regu-
late diverse physiological processes like proliferation, cell
polarity and regulated diVusion. In many diseases, disrup-
tion of this regulated barrier occurs. This review will brieXy
describe the molecular composition of the tight junctions
and then present evidence of the link between tight junction
dysfunction and disease.
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Introduction
Tight junctions (TJ) (zonulae occludentes) form a continu-
ous, circumferential, beltlike structure at the boundary
between the apical and the basolateral membrane domains
in epithelial and endothelial cells. By constituting a regu-
lated diVusion barrier for the paracellular pathway, TJs
establish separate compartments in multicellular organisms
and are also crucial for the exchange of substances between
the internal and external cellular environment by the
expression of tissue-speciWc transport proteins and chan-
nels. The transmembrane proteins constituting the TJs are
attached to the cytoskeleton, thereby linking cell–cell and
cell–substratum adhesion sites. In addition, cytoplasmic
plaque proteins constitute scaVolds for TJ assembly or are
involved in the regulation of processes like transcription,
proliferation and diVerentiation into a tissue-speciWc regu-
lated diVusion barrier in physiology and development.
Many excellent reviews have summarised data regarding
the molecular composition and function of TJs (Ebnet
2008; Gonzalez-Mariscal et al. 2003; Matter and Balda
2003a; Mitic and Anderson 1998; Schneeberger and Lynch
2004; Tsukita and Furuse 1999; Zahraoui et al. 2000), so
that the scope of the current review is focused on distur-
bances of TJ function in human diseases.
Structure of the tight junction
As the apicalmost part of the junctional complex (Farquhar
and Palade 1963), the TJ forms a continuous, circumferen-
tial belt separating apical and basolateral plasma membrane
domains, working as a barrier within the intercellular space
and as a fence within the plasma membrane. In recent
years, information on the molecular composition of TJs, in
particular their transmembrane molecules, has accumu-
lated, forming the basis of our current understanding of the
structure and function of TJs in molecular terms (Fig. 1).
The morphology of TJs has been intensively analysed by
freeze–fracture electron microscopy (Staehelin 1973; Wol-
burg et al. 2003), where they appear as a set of continuous,
anastomosing transmembraneous particle strands on the
inner leaXet of the plasma membrane (P-face) with comple-
mentary vacant grooves on the outer leaXet (E-face)
(Fig. 2). The number and complexity of ramiWcation of the
network of TJ strands depends on the cell type, in sum
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yielding diVerences in permeability barrier function
between diVerent tissues (Staehelin 1973). However, since
a direct linear relationship between the complexity of the
TJ strand network and the measured transepithelial electri-
cal resistance (TER) could not unambiguousy be estab-
lished for all cell types analysed, it was predicted that the
strands might contain pores that Xuctuate between open and
closed conformations, suggesting that the TJ strands appear
to be remarkably dynamic (Claude 1978).
Occludin
Recent identiWcation of the TJ-speciWc integral membrane
proteins forwarded our understanding of TJ molecular com-
position in mammals: occludin (ca. 60 kDa) was identiWed
as the Wrst integral membrane protein localised at TJs in
chicken (Furuse et al. 1993) and then also in mammals
(Ando-Akatsuka et al. 1996). The occludin transmembrane
domain spans the membrane four times with a short cyto-
plasmic N-terminus and an especially long corboxy-termi-
nal cytoplasmic domain (Fig. 3a). Occludin localizes to the
TJs, and its overexpression increases TER in mammalian
epithelial cells (Balda et al. 1996). However, transfection of
insect cells devoid of endogenous TJs with occludin cDNA
surprisingly demonstrated that occludin is not by itself
suYcient to form TJ strands but its expression merely pro-
duced focal homophilic adhesion sites (Furuse et al. 1996).
Moreover, disruption of both occludin alleles in embryonic
stem cells did not prevent the formation of an eVective
diVusion barrier and the polarisation of epithelial cells, as
shown by freeze–fracture analysis and TER assessment
(Saitou et al. 1998). It was thus concluded that occludin is
not required for the formation of TJ strands. However,
occludin appears to interact, directly or indirectly, with
claudins and is recruited into the long strands formed by
Fig. 1 Molecular composition of tight junctions. The transmembrane
proteins occludin, the claudin(s) and junctional adhesion molecule-1
(JAM-1) constitute the barrier formed by TJs sealing the paracellular
space. They appear to be interacting in a homophilic manner, and
occludin seems to co-polymerase into claudin-based TJ strands. Clau-
dins adhere with each other in a homotypic as well as a heterotypic
manner. ZO-1, -2, and -3 bind the cytoplasmic tail of occludin and link
the TJ to the actin cytoskeleton. Proteins of the ZO family can shuttle
to the nucleus to inXuence transcriptional processes in cellular
proliferation and diVerentiation. The ZO-proteins have also been
shown to interact with claudins and provide molecular scaVolds for TJ
assembly. Cingulin is a 140 kDa TJ plaque protein which assoicates
with the actomyosin cytoskeleton. Its putative function is transduction
of the mechanical force generated by the actomyosin cytoskeleton
important for cellular diVerentiation. The Ras target AF-6 interacts
with ZO-1 and serves as a. peripheral component of tight junctions in
epithelial cells. Symplekin is a 126 kDa protein that occurs and
probably functions in the nucleus as well as in the TJ plaques. Tyrosine
phosphorylated Par3 regulates tight junction assembly and promotes
cellular polarity by intracellular signalling. Localization of 7H6
TJ-associated antigen along the cell border of vascular endothelial
cells has been shown to correlate with paracellular barrier function.
Additional proteins have been localised to the TJs but a function has
presently not been assigned. Moreover diverse signaling proteins are
detected at the apical junctional complex but they are not uniquely
conWned to the TJHistochem Cell Biol (2008) 130:55–70 57
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coexpression of claudin-1 and claudin-2 (Furuse et al.
1998b,  1999). Balda et al. (1996) however reported that
overexpression of both, wild type and COOH-terminally
truncated occludin overexpression in cultured MDCK epi-
thelial cells induces not only a modest increase in TER but
also signiWcant increase in the Xux of the non-charged com-
pound FITC-dextran 4 kDa. Using freeze–fracture electron
microscopy and immunocytochemistry, they were able to
attribute this increase in paracellular permeability to an
altered distribution and membrane topology between neigh-
bouring cells.
The claudins
Searching for the proteins forming the structural backbone
of the TJ strands, the Tsukita group re-examined the junc-
tional fraction prepared from chicken liver and discovered
the Wrst members of the claudin family: two 22-kDa pro-
teins, claudin-1 and claudin-2 (Furuse et al. 1998a).
The claudins also have four transmembrane domains,
but do not show any sequence similarity to occludin
(Fig. 3b). So far, 24 members of the claudin family have
been identiWed in diVerent species. Claudins appear to be
expressed in a tissue-speciWc manner; some claudins are
expressed only in speciWc cell types, e.g. claudin-5 is
expressed primarily by vascular endothelial cells or clau-
din-11 appears to be expressed solely in oligodendrocytes
and Sertoli cells (Morita et al. 1999). Moreover, most cell
types express more than two claudin isoforms conferring
diVerent size and charge selectivity qualities by the amino
acid sequence of their extracellular loops, and the combina-
tion of those isoforms results in cell- or tissue-type speciWc
barrier function by “heteropolymerisation” into the result-
ing TJ strands (see below). As demonstrated by immuno-
gold electron microscopy, there is accumulating evidence
now that the claudins do constitute the TJ strands as
observed by freeze–fracture electron microscopy (Tsukita
et al.  2001). Exogenous expression of claudins in Wbro-
blasts devoid of endogenous TJs resulted in the formation
of TJ strands.
Summarizing existing data, there is clear evidence that
the claudins constitute the backbone of TJ strands, while
occludin, which itself cannot reconstitute such TJ strands,
seems to play a permeability regulating role by incorporating
itself into the claudin-based strands, a process, the mecha-
nism of which however is not yet understood. The func-
tion(s) of occludin thus still remain to be elucidated.
Junction-associated adhesion molecules (JAMs)
A third class of integral membrane proteins comprises
members of the immunoglobulin superfamily (Fig. 3c), and
can be subdivided into a group consisting of JAM proteins
and a group consisting of CAR, CLMP, ESAM and JAM-4
(Ebnet 2008; Ebnet et al. 2004). To date, at least three JAM
isoforms have been described, which are expressed diVer-
entially in epithelial and endothelial cells, but also in cells
devoid of TJ strands like leukocytes (D’Atri and Citi 2002).
Except for JAM-1, little is known about the role of these
proteins in TJ assembly and function. JAM-1, formerly F11
receptor (Sobocka et al. 2000) (Fig. 3c), may be involved in
immune cell transmigration or cell adhesion (Bazzoni et al.
2000) but has not been localized to the junction strands. A
putative PDZ binding motif in the cytoplasmic domain of
JAM-1 has been identiWed, which has been able to interact
with PDZ domains of ZO-1, AF-6, PAR-3 and MUPP1
(D’Atri and Citi 2002; Itoh et al. 2001). Moreover, JAM-1
has been shown to interact with cingulin. Thus, even
though JAM-1 is not part of the TJ strands, it may well be
involved in the propagation of signal cascades resulting
from homophilic and heterophilic adhesion. A role for
JAM-1 in the complex process of adhesion and transmigra-
tion of monocytes through endothelial cells has been dem-
onstrated (Martin-Padura et al. 1998). As another function
Fig. 2 Freeze–fracture image of the rat intestinal epithelium. The
freeze fracture electron micrograph showns the apical brush border, the
intramembraneous particle strands of the TJs and the lateral cell sur-
face. The replica shows a continous network of TJ strands. Adapted
from (Achler et al. 1989) with permission from D. Drenckhahn, Uni-
versität Würzburg. Bar 0.5 m58 Histochem Cell Biol (2008) 130:55–70
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for the JAM proteins, a role in the assembly of TJs and
regulation of paracellular permeability could be deciphered
by ectopic transfection experiments (Cohen et al. 2001).
Interaction of JAM-1 with occludin, so far not determined
whether direct or indirect in nature, has been shown (Liu
et al. 2000).
TJ plaque proteins and the coordination of signaling 
at the TJ
In addition to their prime function as a regulated permeability
barrier in the paracellular pathway and as fence in the plane
of the membrane, TJs play a pivotal role in organizing such
diverse processes as morphogenesis, cell polarity, cell
proliferation, and diVerentiation, which require the coordi-
nation of signals impinging on and emanating from the
plasma membrane. Mounting evidence suggests that the
cytosolic TJ plaque is one of the sites in which such signal-
ing is coordinated (Ebnet 2008; Gonzalez-Mariscal et al.
2003; Schneeberger and Lynch 2004). Since identiWcation
in 1986 of zonula occludens (ZO)-1 as the Wrst TJ-associ-
ated protein (Stevenson et al. 1986), almost 30 additional
proteins have been described associated with the cytoplas-
mic aspect of TJs (Schneeberger and Lynch 2004). They
can be grouped into two major categories: The Wrst are the
peripherally associated scaVolding proteins like ZO-1 (ZO-
2, ZO-3, AF6, and cingulin) that appear to organize the
transmembrane proteins and couple them to other cytoplas-
mic proteins and to actin microWlaments. The second are
numerous “signaling” proteins (ZONAB, RhoA, RalA, and
Raf-1) proposed to be involved in junction assembly, bar-
rier regulation, gene transcription, and perhaps other, pres-
ently undeWned pathways.
Fig. 3 Transmembrane proteins of the tight junction. a Murine occlu-
din is a 521 amino acid protein. The Wrst extracellular domain may be
involved in cell–cell interaction containing a high tyrosine and glyine
domain (triangles), acidic amino acids (orange-red), basic amino acids
(green), neutral amino acids (cream). A second functional domain was
assigned to the carboxy terminal 150 amino acids which appears to be
responsible for the association of occludin with ZO-1. The occludin
amino acid sequence is highly conserved between species (Ando-Akat-
suka et al. 1996). b Claudins are four transmembrane domain proteins,
containing two extracellular and one intracellular loop and a N- and
C-terminal cytoplasmic domain. Claudins are a multigene family with
so far 24 members identiWed in diverse species. In the Wrst extracellular
loop, claudins have a conserved common motif, GLWxxC(8–10aa)C
(blue). Claudins further contain a PDZ-binding motif at the C terminus
(orange) capable of bining to TJ plaque proteins like ZO-1. The clau-
dins show a isotype-speciWc tissue expression pattern. c JAM-1 is an
integral membrane protein expressed in endothelial and epithelial
cells. Its extracellular domain can dimerize and bind homophilically.
The intracellular domain (and in particular a PDZ-binding motif) en-
able JAM-1 to interact with structural and signaling proteins. JAM-1 is
localized at the tight junctions of epithelial and endothelial cells and is
involved in the regulation of junctional integrity and permeability. The
polypeptide sequence of 299 amino acids has the typical feature ob-
served in a type I integral membrane protein. A putative signal peptide
may be cleaved between Leu23 and Val24 (pink), leaving 215 residues
in the extracellular domain of the mature protein. A stretch of 17
hydrophobic residues (Ile 239 ! Phe 255) presents a potential trans-
membrane region, and there are 45 residues in the cytoplasmic domain.
The extracellular portion contains two domains with intrachain disul-
Wde bonds typical of immunoglobulin-like loops of the V-type. Numer-
ous PKC (blue) and Casein kinase II (yellow) phophorylation sites
have been detected involved in platelet activation processes (Sobocka
et al. 2000). Cys-43, -111, 146, -214 form dimer containing disulWde
bridges and are labeled in blackHistochem Cell Biol (2008) 130:55–70 59
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TJs as permeability barrier
One of the key functions of tight epithelia is the creation of
a diVusion barrier by tight control of the transcellular and
paracellular pathways. This is acomplished by asymmetri-
cal distribution of transporters and channels for the trans-
cellular route, and on the other side by regulation of
diVusion through the paracellular space via integral TJ pro-
teins (Turner 2006). Hereby, certain claudins participate in
the formation of ion-selective pores: available data suggest
that TJs on the one hand are permeable to small noncharged
solutes up to a size of 0.43–0.45 nm in radius as shown by
the use of the membrane-impermeant polyethylene glycol
as a tracer, but investigations also showed that pores within
the TJs are capable of discriminating between ion charge
and size, which both are additionally dependent on concen-
tration and pH (Schneeberger and Lynch 2004; van Bree
et al. 1988).
The two extracellular loops of occludin consist solely of
uncharched amino acid side chains (Fig. 3a) represented
mainly by an unusually high content of tyrosine and glycine
(Furuse et al. 1993) so that a direct role for occludin in con-
ferring charge selectivity is doubtful. However, occludin
could increase electrical resistance by interaction with the
extracellular domains of the diVerently charged residues of
the diVerent claudins (see below), since ablation of occlu-
din is not without consequence despite the fact that the pro-
tein does not appear to be required for TJ strand formation.
Occludin-null mice express a complex phenotype, which is,
however, not manifested by structural or functional TJ
abnormalities: in occludin ¡/¡ mice, TJs were not aVected
morphologically, and electrophysiological barrier function
of intestinal epithelium was normal. However, histopa-
thological abnormalities were detected in several tissues,
i.e., chronic inXammation and hyperplasia of the gastric
epithelium, calciWcation in the brain, testicular atrophy, the
loss of cytoplasmic granules in striated duct cells of the
salivary gland as well as the thinning of the compact bone,
pointing to complex functions of the occludin protein
(Saitou et al. 2000).
Role of claudin proteins in formation of a TJ 
permeability barrier
The lack of charged amino acid residues within the extra-
cellular loops of occludin segregates occludin from the
candidates contributing directly to the formation of ion-
selective pores. The diVerent claudins whose extracellular
loops span a wide range of pKi on the contrary appear to be
excellent candidates to mediate ion selectivity in TJ perme-
ability (Fig. 3b). Major insight into the distinct charge
selectivity of the claudins came from the work of Furuse
et al. (2001), who could relate the diVerent levels of resis-
tance between MDCK I cells (TER > 10,000 cm2) and
MDCK II cells (TER <200 cm2) to a diVerential claudin
isoform expression, while MDCK I cells express claudin-1
and -4 but not claudin-2, MDCK II cells additionally
express claudin-2, which seems to mediate higher ion per-
meability by pore formation/inducing strand breaks. Nota-
bly, transfection of the tight MDCK I with claudin-2 cDNA
resulted in 20-fold decline in TER but not in the number of
TJ strands.
A wide range of further transfection and mutagenesis
experiments introducing or ablating diVerent claudins has
been performed to date, and been partially helpful to eluci-
date the conductance conferring properties of the resulting
pores (Matter and Balda 2003b). These informative obser-
vations must however be viewed with some caution
because transfection and site-directed mutagenesis may
lead to more than a change in net charge as for example an
altered molecular conformation, or altogether the introduc-
tion of an unusual claudin protein could lead to disturbance
of strand organisation within native strands. By the con-
struction of chimera, Colegio et al. (2003) were moreover
able to attribute ion selectivity of the claudins to distinct
stretches within the primary amino acid sequence of the
extracellular loops leading to alterations in TER and charge
selectivity in transfection experiments. Taken together,
available data strongly suggest a key role for the extracellu-
lar loops of the diverse claudins in the formation of ion
selective pores within the TJ strands.
Role of occludin in formation of a TJ permeability 
barrier
The role of occludin in TJs and a putative contribution to
building up the TJ’s ion selectivity (the ion pores) is
unclear; it has been demonstrated that overexpression of
occludin in MDCK cells reduces ion permeability but in the
same time was shown to increase the transepithelial Xux of
the uncharged compound mannitol (Balda et al. 1996). Fur-
ther observations then implicated that occludin may be a
target for receptor-initiated signalling involving the Rho
family of GTPases, and that by an additional not-yet-under-
stood mechanism, occludin phosphorylation may regulate
TJ permeability independently of cytoskeletal activity (Hir-
ase et al. 2001).
Some indirect evidence for a role of occludin in strength-
ening barrier properties arose from heterologous expression
studies: when expressed in L-Wbroblasts that lack endoge-
nous cadherin-based adherens junctions and ZO-1, little
adhesiveness was measured (Kubota et al. 1999). However,
when overexpressed in Wbroblasts, which do have well
developed ZO-1-containing adherens-like junctions (NRK-60 Histochem Cell Biol (2008) 130:55–70
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Wbroblasts), increased Ca2+-independent adhesion was
observed, indicating that when interacting with ZO-1,
occludin mediates adhesive functions (Van Itallie and
Anderson 1997). Addition of neutralizing peptides of the
peptide sequence of the second extracellular loop elicited
competitive interference with cell–cell-adhesion in a dose
dependent manner, implicating that this loop directly par-
ticipates in adhesive interaction (Wong and Gumbiner
1997).
Relating epithelial malignancy to the loss of cell–cell-
adhesion, it was demonstrated that overexpression of onco-
genic Raf 1 in rat salivary gland epithelial cells (Pa4–Raf1)
disrupts TJs and induces an oncogenic phenotype by down-
regulating the expression of occludin (Wang et al. 2005).
Raf1-mediated transformation of Pa4–Raf1 cells was sub-
sequently shown to induce transcriptional downregulation
of occludin and forced re-expression of occludin rescued
the polarized phenotype of epithelial cells (Wang et al.
2007). Interestingly, forced expression of an occludin
mutant lacking the second extracellular loop did not rescue
the epithelial phenotype in vitro nor did it prevent tumor
growth in vivo. These results demonstrate that the TJ pro-
tein occludin has a potent inhibitory eVect on the Raf1-
mediated tumorigenesis, and the second loop of occludin
appears to be required for suppression of Raf1-induced
tumor growth, potentially by mediating cell–cell-adhesion
as presented above contributing to contact inhibition of cell
division.
TJs and human disease
Modulation of barrier function by cytokines
Many cytokines have been shown to inXuence epithelial
and endothelial TJ function and the actin cytoskeleton both
in vivo and in vitro. To name the most prominent, the inter-
leukins IL-0, IL-1, IL-3, IL-4, as well as tumor necrosis
factor alpha (TNF) and interferon gamma (IFN) could be
demonstrated to inXuence TJ barrier function in epithelia
and endothelia (Ahdieh et al. 2001; Oshima et al. 2001;
Youakim and Ahdieh 1999). This review will emphasise
the inXuence of a few selected cytokines on TJ structure/
function and its adjoining actin cytoskeleton in diseases
like inXammatory bowel disease and inXammatory disease
of the CNS (Table 1).
InXammatory bowel disease: Crohn’s disease
Crohn’s disease ranks among the chronic inXammatory
bowel diseases (IBD) with diarrhoea as a leading symptom.
This is chieXy attributed to epithelial barrier dysfunction,
Table 1 Modulation of TJ barrier function in human disease
ClassiWcation Tight junction protein aVected Reference
Cancer
Breast cancer: invasive ductal cancer Claudin-1, ZO-1 Itoh and Bissell (2003), detailed here
Prostate cancer: prostatic adenocarcinomas Claudins-1, -3, -4 and claudin-7 Sheehan et al. (2007)
Thyroid neoplasma, follicular adenoma Occludin and claudin-1, -4 and -7 Tzelepi et al. (2007)
Gastroesophageal reXux disease: 
Barrett’s esophagus  (dysplasia)
Claudin-18 Jovov et al. (2007)
Lung cancer: Basaloid squamous carcinoma Ultrastructural junctional 
dediVerentiation
Gilcrease and Guzman-Paz (1998)
InXammation
InXammatory bowel disease: Morbus Crohn Claudins-2,-3, -5, and -8, ZO-1 Zeissig et al. (2007), detailed here 
Collagenous collitis Occludin, claudin-2 and -4 Burgel et al. (2002)
Multiple sclerosis Occludin, claudin-5 Förster et al. (2007), detailed here
Hereditary diseases
Hereditäry deafness Claudin-14 Ben-Yosef et al. (2003), detailed here
Familial hypomagnesemia Claudin-16 Simon et al. (1999), detailed here
cystic Wbrosis Occludin, claudin-1, -4, JAM, ZO-1 Coyne et al. (2002)
Vision loss
Diabetic eye disease: diabetic retinopathy Occludin, ZO-1 Felinski and Antonetti (2005), detailed here
Viral infection
Reoviral infection (hydrocephalus, encephalitis) JAM-1 Forrest et al. (2003)
Bacterial toxins
Clostridium perfringens enterotoxin Claudin-3 and -4 McClane (2001), detailed hereHistochem Cell Biol (2008) 130:55–70 61
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leading to an increased loss of solutes in the form of “leak-
Xux diarrhoea”. Notably, the integrity of the intestinal bar-
rier is not only impaired in patients with Crohn’s disease
but also many Wrst-degree relatives of Crohn’s disease
patients present with increased intestinal permeability in
the absence of clinical symptoms (Hollander 1993; Peeters
et al.  1997; Yacyshyn and Meddings 1995). From this
observation it was concluded that barrier dysfunction in
Crohn’s disease precedes the inXammatory process in con-
trast to many other inXammatory diseases, probably arising
from genetic defects or driven by environmental factors
like intestinal luminal antigens or bacterial toxins.
The epithelial barrier in the intestine is established by a
single layer of epithelial cells. However, barrier dysfunc-
tion alone does not to seem be suYcient to cause Crohn’s
disease, since unaVected relatives of patients with Crohn’s
disease comparably present increased permeability, but do
not show the abnormal mucosal inXammatory response
reported of patients with Crohn’s disease (Weber and
Turner 2007). In healthy individuals, the intestinal muco-
sal barrier is organised through tight junction strands con-
necting the adjacent epithelial cells (Weber and Turner
2007). These TJs seal the paracellular space and an intact
intestinal mucosa. TJ permeability is rate limiting for epi-
thelial permeability and defects thereof are an established
source for intestinal barrier defects as observed in Crohn’s
disease. The basic understanding of TJ function we devel-
oped is that they form an ion-selective and size-selective
paracellular gate whose permeability varies throughout the
gastrointestinal tract (see above). According to this, it is
not surprising that the pattern of claudin isoforms
expressed varies alongside the gastrointestinal tract (Nus-
rat et al. 2000). Recent studies now  show that the expres-
sion pattern of characteristic claudins is altered in Crohn’s
disease (Weber and Turner 2007) with a concomitant
eVect on the integrity of TJ strands: Zeissig et al. (2007)
showed by freeze–fracture electron microscopy that the
overall number of TJ strands sealing the epithelial layer is
reduced while concomitantly an increased number of
strand breaks was noted in tissue from patiens with
Crohn’s disease (Zeissig et al. 2007). The expression of 12
claudin isoforms in the intestinal epithelium was investi-
gated in healthy individuals and patients with Crohn’s dis-
ease, leading to the insight that the expression of the
claudins-3, -5, and -8 was decreased in active disease. On
the contrary, expression of barrier-reducing claudin-2 was
increased in histological samples from patients, which was
particularly observed in the crypt epithelium. This altered
pattern of claudin isoform expression was thus concluded
to be partly responsible for the observed mophological and
functional disruption of TJs. However, claudin isoform
expression patterns were unaltered in patients with inac-
tive Crohn’s disease, rendering this observed change in
expression patterns rather a consequence than a cause of
active disease.
It is has been acknowledged for a long time that chronic
inXammation in Crohn’s disease is associated with the
overproduction of proinXammatory cytokines. Searching
for the nature of these pro-inXammatory mediators eVecting
the TJ disruption and dysfunction, investigators (Conyers
et al. 1990; Heller et al. 2005; Prasad et al. 2005) had iden-
tiWed IL-13, IFN and TNF as factors in patient’s serum
lowering resistance and opening TJs. However, diVerential
eVects of the diVerent cytokines crititical to IBD pathogenis
have been reported from studies in cell culture models,
indicating that the mechanisms by which IFN and TNF
inrease paracelluar permeability diVer from those used by
IL-13 (Prasad et al. 2005). IFN and TNF exposure of
model cell lines led to a reduction in claudin-2 expression,
while IL-13 exposure induced increased claudin-2 expres-
sion. Those observed discrepancies, which might be based
on the source of epithelial cell lines, the experimental
design or the doses of cytokines applied are the focus of
current investigation. Other lines of research are concen-
trated on gaining more information on the source of pro-
inXammatory cytokines in IBD and the mode how those
cytokines may work together to modify claudin expression
pattern, either in vitro or in vivo (Weber and Turner 2007).
At the cell biological level, recent investigation demon-
strated that IFN exposure promoted the endocytosis of
occludin, JAM-1 and claudin-1 into early and recycling
endosomes (Bruewer et al. 2005), an eVect which appears
to be mediated by RhoA/Rho kinase, which further induced
a myosin II-dependent formation of vacuoles in the apical
cell moiety (Utech et al. 2005).
At the gene expression level, other research groups
could demonstrate that TNF induced an increase in Caco-2
TJ permeability mediated by activation of the pro-inXam-
matory transcription factor NFB. NFB action leads to a
downregulation of speciWcally ZO-1 gene expression and a
redistribution of ZO-1 protein away from the intercellular
junctions (Ma et al. 2004). A comparable eVect could be
described in the nonintestinal model epithelial cell line,
MDCK, and in the blood brain barrier model cell line
cEND, where also disruption of TJs following exposure of
epithelial and endothelial cells to TNF could be demon-
strated (Förster et al. 2007; Poritz et al. 2004).
Blood-brain barrier compromise 
in neuroinXammation–multiple sclerosis
Homeostasis of the central nervous system (CNS) microen-
vironment is essential for its normal function. It is main-
tained by the blood-brain barrier (BBB) which regulates the
transport of molecules from blood into brain and back-
wards. The function of this highly specialised barrier is to62 Histochem Cell Biol (2008) 130:55–70
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(1) protect the brain from blood-borne substances and (2) to
provide nutrient supply to the brain parenchyme by specia-
lised transport systems (Rubin and Staddon 1999).
The main structures responsible for this barrier property
are the TJ. TJ are strongly developed in endothelial cells of
the BBB but only moderately formed between endothelial
cells of the peripheral vasculature: leaky blood vessels in
the body allow many molecules to cross through to tissue,
but the tight construction of the vessels in the CNS guards
against brain entry, leading to high electrical resistance in
the range of 1,500—2,000 cm2, depending on the species
investigated. In BBB-forming brain capillary endothelial
cells (BCECs) the TJ proteins occludin and claudin-5, clau-
din-3, claudin-1 and claudin-12 were demonstrated by
immunoXuorescence and western blot analysis (Förster
et al. 2007; Wolburg and Lippoldt 2002).
Under physiological conditions, brain microvascular
endothelial cells form a barrier limiting the extravasation of
cells of the immune system like monocytes, lymphocytes
and other leukocytes. It has been shown in this context that
leukocytes can transmigrate to the BBB without net
changes in vascular permeability and cell–cell contacts
(Cramer 1992). However, increased leukocyte migration as
in multiple sclerosis (MS) has been reported to lead to a re-
organisation of the actin cytoskeleton and breakdown of the
TJ proteins occludin and ZO-1 (Couraud 1998; Förster
et al. 2007). MS is characterised as a chronic and progres-
sive CNS disease with a remitting-relapsing proWle. In the
course of the disease, both demyelination and microvascu-
lar inXammation have been described as central patho-
physiological insults. From an animal model for MS,
experimental allergic encephalomyelitis (EAE) (Korner
and Sedgwick 1996), the inXammatory cytokines TNF and
IL-1 have been delineated to be the key mediators inducing
alterations in BBB permeability. Clinically matching data
have been collected from MS patients, who show an eleva-
tion in TNF and/or IL-1 in cerebrospinal Xuid (CSF)
(Weber and Rieckmann 1995). Cytokine-promoted opening
of the BBB has been shown to occur due to degradation and
decreased synthesis of TJ proteins (Chang and Werb 2001;
Harkness et al. 2000; Silwedel and Förster 2006; Yang
et al. 2006), resulting in compromised junctional integrity.
Particularly, the TJ proteins occludin and ZO-1 have been
shown to be negatively aVected by the presence of these
pro-inXammatory cytokines. Searching for the mechanism
of TJ protein degradation, consecutive studies showed, that
in many neuroinXammatory conditions, including MS, the
matrix metalloproteinases (MMP) play an important role in
disrupting the BBB. Amongst these, it has been demon-
strated that selectively, MMP-9 (gelatinase B) is increased
in CSF levels in MS patients. Tissue inhibitors of metallo-
proteinases (TIMPs) form complexes with either activated
MMPs or with their pro-forms after their secretion, thus
regulating MMP activity under physiological conditions
(Brew et al. 2000; Yong et al. 2001). Levels of TIMP-1 are
however reduced in MS patients relative to control patients,
suggesting an imbalance in MMP-9/TIMP-1 ratios in MS
(Avolio et al. 2005). MMP-9-mediated opening of the BBB
then allows ampliWcation of the inXammation, as demon-
strated by radioisotopes (Kermode et al. 1990). Looking for
therapeutical agents restoring the unbalaced MMP-9/
TIMP-1 ratios in MS, Förster et al. (2007)  showed that glu-
cocorticoid treatment reduces the levels of MMP-9 mark-
edly in a cell culture model of the BBB, an eVect which was
shown to be based on glucocorticoid-mediated transcrip-
tional activation of the TIMP-1 gene. This study further
demonstrated that the administration of the glucocorticoids
dexamethasone and hydrocortisone preserved the func-
tional integrity of the TJs and adherens junctions under pro-
inXammatory conditions, chieXy by maintaining the levels
of the TJ components occludin, claudin-1, claudin-12, ZO-
1 and VE-cadherin, while dexamethasone eVects on clau-
din-5 were negligible (Blecharz et al. 2008; Förster et al.
2007).
Another study demonstrated diVerential susceptibility
of cerebral and cerebellar endothelial cell lines to BBB
breakdown in response to inXammatory stimuli (Silwedel
and Förster 2006): increased fragility of the cerebellar
BBB had been reported, as the typical caudal to rostral
lesion development of MS and EAE with a preference of
the cerebellum indicates (Cross et al. 1993; Juhler et al.
1984; Namer et al. 1993). Matching those studies, the
authors could demonstrate a faster and more pronounced
increase in permeability in the cerebellar BBB manifested
by reduced TER and reduced TJ protein expression using
the cerebellar BBB model cell line cerebEND (Silwedel
and Förster 2006). The stronger eVects of TNF on endo-
thelial cells of the cerebellum as compared the the cere-
brum could be explained on the cellular level, where the
TJ protein levels of claudin-5 and occludin were shown to
be diVerently aVected in cerebellar and cerebral microvas-
cular endothelial cells: eVects on occludin were more pro-
nounced in cerebellar endothelial cells, while cerebral
endothelial cells of the BBB showed a stronger decrease in
claudin-5. Since it was shown that the main protein buid-
ing up the barrier appears to be occludin, while claudin-5
protein, which is also well detectable in non-BBB endo-
thelial cells, does not seem to inXuence barrier properties
to the same extent (Foerster et al. 2002, 2005, 2006; Wol-
burg and Lippoldt 2002). One may speculate that the lower
overall occludin contents of endothelial cells of the cere-
bellar BBB compared to the cerebral BBB can partly
explain the greater sensitivity of the cerebellar BBB to
inXammatory stimuli.Histochem Cell Biol (2008) 130:55–70 63
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Hereditäry diseases
Hereditäry deafness: nonsyndromic recessive deafness 
DFNB29
The cochlea of the inner ear is divided into two compart-
ments of diVerent ionic composition. Hereby, the peri-
lymph of the scala vestibuli and scala tympani is high in
Na+ but low in K+ concentration, while the endolymph of
the scala media resembles the intracellular ionic composi-
tion, being high in K+ but low in Na+ (Ferrary and Sterkers
1998). This ion gradient leads to the establishment of an
80–100 mV endocochlear potential, necessary for the depo-
larisation of sensory hair cells, enhancing the sensitivity of
mechano-activated channels at the top of stereocilia (Hud-
speth 1989).
Besides, hereditary defects in the gap junction proteins
connexin-26 and connexin-43 (Sabag et al. 2005) an associ-
ation between tight junctions and hearing loss was estab-
lished. The importance of claudin-14 expression in the
cochlea was demonstrated by the identiWcation of two
diVerent  CLDN14 mutations that cause nonsyndromic
recessive deafness DFNB29 in two large consanguineous
Pakistani families (Wilcox et al. 2001). By in situ hybridiza-
tion and immunoXuorescence labeling mouse claudin-14
expression in the sensory epithelium of the organ of Corti
was observed. By the generation and characterisation of
claudin-14 knockout mice as a model for autosomal-reces-
sive deafness DFNB29 it was revealed that deafness
occurred due to death of outer hair cells. Searching for the
factors that promoted increased death of outer hair cells,
morphology of the TJs of claudin-14 knockout mice was
evaluated. It was demonstrated that TJ strands between sup-
porting cells and between outer hair cells and supporting
cells in the organ of Corti are still present and appear mor-
phologically normal in freeze fracture replicas. The ana-
lysed TJ strands which are composed of multiple claudins
were thus concluded to have rather a functional than  an
ultrastructural defect (Ben-Yosef et al. 2003). Following
the reasoning that claudins create charge-selective chan-
nels, Ben-Yosef characterised the electrophysiologic prop-
erties of claudin 14 by ectopically expressing it in MDCK
cells, which revealed a strong discrimination of transfected
monolayers against Na+ and K+ ions. Ben-Yosuf and
coworkers thus concluded that the absence of claudin 14
from TJs in the organ of Corti might lead to elevated K+
concentration in the space of Nuel, which is normally Wlled
with the K+-poor cortilymph and increased death of outer
hair cells. Long-term exposure of the basolateral mem-
branes of outer hair cells to high K+ concentrations had
been shown to be toxic and eventually to lead to cell death
before (Zenner 1986).
By the identiWcation of two claudin-14 missense muta-
tions that were unable to form TJs after ectopic expression
of  CLDN14 in L mouse Wbroblastes, Wattenhofer et al.
(2005) were then able to prove that the basis for the develop-
ment of deafness is incorrect recruitment and TJ strand
formation in cells expressing mutated CLDN14.
Familial hypomagnesemia with hypercalciuria 
and nephrocalcinosis (FHHNC)
Inherited and acquired defects in epithelial membrane
transport are responsible for many human diseases. In the
kidney, tubular claudins play a role in extracellular or para-
cellular permeability. In this context, it has been shown that
mutations in claudin-16 (Paracellin-1) impair the function
of TJs in the paracellular resorption of Mg2+ and Ca2+ but
not of monovalent cations (Simon et al. 1999), probably
founding the molecular basis for the development of familial
hypomagnesemia with hypercalciuria and nephrocalcinosis
(FHHNC), an autosomal recessive renal tubular disorder. In
FHHNC patients, the impaired tubular reabsorption of
Mg2+ and Ca2+ in the thick ascending limb of the loop of
Henle with an eventual progression can lead to end-stage
renal disease (Lee et al. 2006). Functional tubular reabsorb-
tion mechanisms are vitally important, since a normal adult
absorbs only 200 mg Ca2+ from the diet each day, but loses
8,000 mg to Wltration across the glomerulus. To achieve
normal calcium balance, the majority of the Wltered load
must be reabsorbed by the tubule, to approximately 90%, or
7,000 mg/day and this occurs mainly via the paracellular
pathway driven by a lumen positive potential across the
tubular wall.
The structural backbone of the paracellular pathway
must provide for the signiWcant substrate selectivity and
functional heterogeneity between nephron segments and
thus also plays a pathophysiologic role in renal diseases.
Clinically, the symptoms and gradual kidney damage
caused by FHHNC cannot be alleviated by intravenous
or oral supplementation with Mg2+, and kidney trans-
plantation is often the only option at later stages of the
disease.
Recent studies (Simon et al. 1999) have reported that
FHHNC is caused by mutations in a gene, which encodes
the TJ protein, paracellin-1. Paracellin-1 (PLCN-1) belongs
to the claudin family (claudin-16) that allows the paracellu-
lar transport of Mg2+ and Ca2+. As a member of the claudin
family of TJ proteins claudin-16 exhibits four transmem-
brane spans with two extracellular loops and both termini
located in the cytoplasm. To date, more than 20 distinct
mutations have been identiWed, which aVect either the
traYcking of PLCN-1/claudin-16, or its permeability
properties (Kausalya et al. 2006).64 Histochem Cell Biol (2008) 130:55–70
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Interestingly, FHHNC patients do not exhibit the salt
wasting or metabolic alkalosis that is found in Bartter’s
syndrome (Wong and Goodenough 1999). Based on these
Wndings, it is tempting to hypothesize that PCLN-1 might
form a Mg2+- and Ca2+ -conducting pore. It is therefore
likely that PCLN-1 selectively mediates the barrier to diva-
lent but not monovalent cations. Thus, not only can the
paracellular barrier discriminate between charged and
uncharged solutes, but it may also exhibit an even higher
level of speciWcity distinguishing charge and ionic radius
and size of the hydrate shell.
As to molecular investigations based on the use of
diverse cell culture models for kidney epithelial cells, there
is some discrepancy between results obtained upon over-
expression of PLCN-1 in two diVerent kidney epithelial cell
lines used. In the canine MDCK cell line, another group
found PCLN-1 to decrease Na+ permeability, to decrease
TER and to enhance transepithelial Mg2+ transport (Ikari
et al. 2006). Another recent study performed in the porcine
proximal tubule LLC-PK1 cells suggests that paracellin-1
functions to modulate paracellular conductance and not
transcellular transport. They hypothesise that PLCN-1
mediates mostly paracellular Na+ permeation to build up
the positive lumen potential and that this lumen-positive
potential would be the driving force for the reabsorption of
Mg2+ (Hou et al. 2005).
As described for other molecules relevant to Mg2+
homeostasis such as ACDP2, (ancient conserved domain
protein), a divalent metal transporter, or the Mg2+ trans-
porter MagT1 (Wong and Goodenough 1999), the human
PLCN-1 promoter appears to be responsive to external
Mg2+ concentrations, since the renal epithelial cell speciWc
PLCN-1 gene expression was shown to positively correlate
with the amount of Mg2+ oVered in the growth medium
(Efrati et al. 2005).
Further, mutations in PLCN-1 can aVect claudin-16 pro-
tein targeting at the TJs (Kausalya et al. 2006). The muta-
tion T233R for example prevents interaction of claudin-16
with ZO-1 and results in lysosomal targeting of claudin-16
instead. Protein kinase A (PKA) mediates phosphorylation
of claudin-16 at Ser217,  failure of which equally leads to
dissociation of claudin-16 from ZO-1 and its translocation
into the lysosomes (Ikari et al. 2006). In conclusion,
although the mechanism of PLCN-1/claudin-16-mediated
Mg2+ and Ca2+ reabsorbtion is not yet fully understood, it is
clear that these claudins play a crucial role in this process.
Recently, Konrad et al. (2006) additionally unravelled a
role for claudin-19 in the development of FHHNC. They
had clinically characterized one Swiss and eight Spanish/
Hispanic families aVected with severe hypomagnesemia
due to renal wasting, nephrocalcinosis, and progressive
renal failure but had to recognize that the individuals did
not have any mutations in CLDN16. They showed that the
renal phenotype of the aVected patients was virtually undis-
tinguishable from that of patients who presented with
FHHNC with proven CLDN16 mutations. However, the
aVected individuals in these families also have severe
visual impairment, characterized by macular colobomata,
signiWcant myopia, and horizontal nystagmus (Konrad et al.
2006). Konrad et al. were able to map a new locus for
recessive renal magnesium loss on chromosome 1p34.2 and
identiWed mutations in CLDN19, yet another member of the
claudin family in patients aVected with FHHNC and addi-
tionally, with severe ocular abnormalities. CLDN19, which
encodes the tight-junction protein claudin-19 was demon-
strated to be highy expressed in renal tubules and the retina.
In an eVort to understand the mechanisms underlying the
roles of the two claudins in mediating paracellular ion reab-
sorption in the kidney, Goodenough and co workers (Hou
et al. 2008) showed using pig kidney epithelial cells, that
CLDN19 functioned as a Cl(¡) blocker, whereas CLDN16
functioned as a Na(+) channel. Mutant forms of CLDN19
were shown to be associated with FHHNC since they were
unable to block Cl(¡) permeation. Coexpression experi-
ments further elucidated that CLDN16 interacts with
CLDN19 and that their association confers cation selectiv-
ity, suggesting a role for mutant forms of CLDN16 and
CLDN19 in the development of FHHNC.
Vascular system
Diabetic retinopathy
The barrier between the vascular lumen and neural layers in
the retina and the brain parenchyme maintains a charac-
teristic microenvironment and is essential for proper neuronal
function. This blood-retinal barrier (BRB) consists of two
anatomical entities: an inner BRB formed by junctions
between endothelial cells of the retinal capillaries, and an
outer BRB composed of TJs between retinal pigment epi-
thelial cells. Clinical evidence from Xuorescein angiogra-
phy has demonstrated that the inner BRB appears to be the
primary site of vascular leakage leading to macular edema.
The BRB is built up and maintained by TJ complexes
that make up the blood vessels of the microvasculature
(Mitic and Anderson 1998). The principal proteins found in
the retinal endothelial TJs are occludin and claudin-5 (Dej-
ana et al. 2001). Loss of the BRB integrity and vascular
permeability leading to macular edema (Vitale et al. 1995)
characterise diabetic retinopathy. Macular edema in turn is
thought to be directly responsible for vision loss in diabetic
retinopathy (Felinski and Antonetti 2005). Vascular endo-
thelial growth factor (VEGF) is thought to be chieXy
responsible for this increase in BRB permeability, albeit
other permeabilizing factors like histamin or the cytokines
IL-1 and TNF have also been implicated (Felinski andHistochem Cell Biol (2008) 130:55–70 65
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Antonetti 2005). Levels of VEGF, originally identiWed as
an angiongenic factor serving as a mitogen for vascular
endothelial cells have been recently correlated with
increased vascular permeability (Felinski and Antonetti
2005), compatible with increased VEGF levels detected in
the vitreous of diabetic patients for decades. There is
enough evidence to show that diabetes and VEGF induce
retinal vascular permeability by altering TJ complexes, evi-
denced for instance by the decrease in occludin content in
the retinas of diabetic rats (Felinski and Antonetti 2005). In
cultured primary bovine retinal endothelial cells, this obser-
vation was mirrored by the observation of decreased occlu-
din contents after VEGF administration (Antonetti et al.
1998). Follow-up investigation underlined this and showed
down-regulation of occludin in retinal endothelial cells in
culture after VEGF stimulation. VEGF further activates
PKC, which leads to increased occludin and ZO-1 phos-
phorylation (Harhaj et al. 2006). Phosphorylation of
occludin and ZO-1 likely contribute to dysregulated endo-
thelial paracellular permeability (Abbott et al. 2006). Regu-
lation of PKC activity and TJ protein modiWcations may
thus have therapeutic implications for treatment of diabetic
retinopathy.
Recent investigation has further revealed that altera-
tions of the BRB may involve the active proteolytic break-
down of the endothelial cell TJs by MMPs as also
evidenced in the case of MS (compare above) (Leppert
et al. 2001). SpeciWcally, elevated levels of MMP-9 have
been seen when retinal endothelial cells were exposed to
high glucose conditions as a cell culture model of diabetes,
leading to proteloytic degradation of speciWcally the TJ
protein occludin followed by disruption of the overall TJ
complex (Giebel et al. 2005), rendering the regulation of
MMP secretion and activity another therapeutical target in
diabetic retinopathy.
Multiple sclerosis
See above.
Tight junction alterations in cancer
Decreased expression of claudin-1 correlates 
with malignant potential in breast cancer
Changes in TJ function have been shown to be an early and
key aspect in cancer metastasis (Ehler et al. 2001). Recent
studies showed a role for claudin-1 in invasion and metastasis
in mammary glandular diVerentiation (Förster et al. 2002)
and carcinogenesis (Morohashi et al. 2007).
Interestingly, there is an absence or signiWcant loss of
claudin-1 expression in several established breast cancer
cell lines. Claudin-1 expression in primary human mam-
mary epithelial cells, in contrast to low or undetectable
levels of expression in a number of breast tumors and
breast cancer cell lines, points to claudin-1 as a possible
tumor-suppressor gene. In sections from surgically
resected breast specimens, a signiWcant loss of claudin-1
protein in breast cancer cells could be shown by immuno-
histochemistry (Tokes et al. 2005). This Wnding suggests
that claudin-1 may play a role in invasion and metastasis.
The expression proWle of claudin-1 in non-malignant ver-
sus tumor-derived cells has made this gene an interesting
candidate for involvement in tumorigenesis, namely by
acting as a suppressor of mammary epithelial prolifera-
tion.
In order to evaluate the CLDN-1 gene in sporadic and
hereditary breast cancer, Krämer et al. (2000) characterized
its genomic organization and screened the four coding
exons for somatic mutations in 96 sporadic breast carci-
nomas and for germline mutations in 93 breast cancer
patients with a strong family history of breast cancer. In
addition, they compared the 5-upstream sequences of the
human and murine CLDN1 genes to identify putative pro-
moter sequences involved in down-regulation of the
CLDN1 gene under malignant conditions and examined
both the promoter and coding regions of the human gene
in various breast cancer cell lines showing decreased
claudin-1 expression. However, neither in sporadic or
hereditary breast cancers, nor in breast cancer cell lines
they found evidence for a role of aberrant claudin-1 in
breast tumorigenesis and concluded that other regulatory
or epigenetic factors could be involved in the down-
regulation of the CLDN1 gene during breast cancer
development.
A correlation between TJ abnormalities and neoplasia
can be supported by several observations: alterations in the
number, appearance, and permeability of TJs have been
demonstrated in various cancer types (Cochand-Priollet
et al. 1998; Soler et al. 1999; Swift et al. 1983) and in pre-
malignant mammary epithelial cells (Förster et al. 2002).
At the molecular level, the Drosophila lethal(1) discs-large-
1 gene (dlg) product, which localises to TJ-related insect
septate junctions has been shown to regulate epithelial cell
proliferation. Genetic loss of dlg leads to a neoplastic over-
growth phenotype (Woods and Bryant 1991). The loss of
expression of claudin-1 itself has been demonstrated in
several mammary carcinoma cell lines (Swisshelm et al.
1999). The expression of the TJ plaque protein ZO-1 has
been shown to be reduced in breast carcinomas or breast
cancer cells (Hoover et al. 1998). These Wndings support
the hypothesis that claudin-1 might be involved in the
development of breast cancer and possibly in other epithe-
lial tumors too.
The molecular pathways leading toward the loss of clau-
din-1 expression however, remain to be explained.66 Histochem Cell Biol (2008) 130:55–70
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Bacterial toxins
Clostridium perfringens enterotoxin
Food poisoning by Clostridium perfringens enterotoxin
(CPE) leads to diarrhea symptoms classiWed as “C. perfrin-
gens type A food poisoning and antibiotic-associated diar-
rhea”. The enterotoxin protein has been elucidated to
intrude the cells by interacting with epithelial TJ, including
certain claudins. Toxin-induced cytolytic pore-formation is
a prerequisite for this and involves residues in the N-termi-
nal half of CPE protein, while residues near the C-terminus
are required for binding to claudins. In detail, the single
35 kDa CPE polypeptide Wrst causes cellular damage by
altering plasma membrane permeability by the formation of
an approximately 155 kDa CPE-containing pore complex
necessary for the subsequent interaction with TJ proteins
via its C-terminal receptor-binding region (McClane 2001).
CPE was then perceived to aVect TJ structure and function
in a way that permeability properties of the epithelial layer
are altered leading to diarrhea (McClane 2001).
Further investigation has determined the isoforms of
claudins targeted by CPE. Sonoda et al. (1999) were able to
show that the COOH-terminal half fragment of CPE (C-
CPE) bound eVectively to claudin-3 and claudin-4 in
MDCK I cells expressing the claudins-1, -2, -3 and -4.
They were further able to show that in the presence of
C-CPE, reconstituted TJ strands gradually disintegrated
and disappeared from their cell surface in C3L cells.
As a consequence, because diverse claudins are overex-
pressed on some human cancers, the toxin became interest-
ing for targeting chemotherapy in the manner of a Trojan
horse (Long et al. 2001; Michl et al. 2001).
Recently, van Itallie et al. (2007) aimed to solve the
structure of the CPE claudin-binding domain to advance its
therapeutic applications. The structure was shown to be a
nine-strand beta sandwich with previously unappreciated
similarity to the receptor-binding domains of several other
toxins of spore-forming bacteria, giving strong evidence for
the presence of a common ancestor for several receptor-
binding domains of bacterial toxins (Van Itallie et al.
2007). The very recent elucidation of the structure of a 14-
kDa fragment containing residues 194 to the native COOH
terminus at position 319 by X-ray diVraction to a resolution
below 2 Å showed that the structure is a nine-strand  sand-
wich with previously unappreciated similarity to the recep-
tor-binding domains of several other toxins of spore-
forming bacteria, i.e., the collagen-binding domain of ColG
from Clostridium histolyticum and the large Cry family of
toxins (including Cry4Ba) of Bacillus thuringiensis (Van
Itallie et al. 2008). The authors speculate that the claudin-4
binding site is on a large surface loop between strands 8
and 9 or includes both of these strands. They further were
able to clarify that the sequence crystallized binds to puri-
Wed human claudin-4 with a 1:1 stoichiometry. The binding
aYnity was determined to be in the submicromolar range
similar to that observed for binding of native toxin to cells
(Van Itallie et al. 2008). These results could now provide a
structural framework to advance therapeutic applications of
the toxin.
Conclusion and perspectives
The discovery of the existence of occludin- and claudin-
based TJs constituting a permeability barrier in epithelial
and endothelial cells has paved the way for the elucidation
of the molecular background of diverse human diseases the
pathogenesis of which had been unclear before. It became
clear that the presence of TJs is indispensable for tissue
compartmentalisation and cellular homeostasis. Distur-
bances in TJ function are reXected in many diseases, but on
the other hand, awareness of their involvement has facili-
tated therapy enormously. For instance, antiinXammatory
or antimetastatic drugs could be developed based on their
ability to repair broken barrier function. These strategies
have become indispensable in the treatment of disease like
MS, inXammatory bowel disease or diabetic retinopathy.
Following the strategy of pathogenic agents, which use TJ
proteins as a docking station to invade cells, even strategies
for drug delivery techniques could be implemented. Future
attempts will have to address the role of occludin and the
exact contribution of the diverse claudins to the formation
of ion selective pores, which are still open questions. A
more thorough understanding will greatly facilitate diagno-
sis and the development of speciWc treatment regimens for
diseases originating from impaired TJ function.
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